Mead Johnson Nutritionals Spinoff IPO


Busy value investors take the hassle out of screening, valuation and grading stocks with Old School Value. Try the live demo today.

Mead Johnson is finally ready for the market. A spinoff from Bristol Myers Squibb that I think is interesting and will do well.

I’ll have to try and read the prospectus quickly.

Here is a short article from seeking alpha with some details and one from Forbes.

Mead Johnson will start trading on Wednesday under MJN.

Have you read up on Mead Johnson? What do you think?

Busy value investors take the hassle out of screening, valuation and grading stocks with Old School Value. Try the live demo today.

Ready to try Old School Value?

TEST DRIVE THE DEMO TODAY